Annual Meeting of The Society of Gynecologic Oncology
Annie Ellis, Representing SHARE and Ovarian Cancer National Alliance
I had an opportunity to attend the 2012 Society of Gynecologic Oncology (SGO) annual meeting in Austin, Texas. It is always exciting to hear about the latest developments in ovarian cancer treatment, witness dialogue between doctors and hear of collaborations and data sharing. While those are encouraging, there did not appear to be any huge discoveries this year. Most of the research presented requires further study to validate and it is going to take some time for researchers to continue to analyze the massive amount of data from the Cancer Genome Project. The SGO voted to include non-surgical professionals (including medical oncologists, radiation oncologists and nurses) to unite “all members of the gynecologic oncology team in an effort to eradicate women’s cancer.”
My favorite highlights from this year’s meeting:
- New clinical trials for specific cell types: clear cell, low grade serous and mucinous.
- A session on Palliative Care and Bowel Obstructions: Some gynecologic-oncologists are getting board certified in palliative care to provide aggressive symptom management to improve quality of life for patients.
- A small single-institution study of long term survivors with no recurrence which identified three genes as possible targets for further study.